MedPath

Exercise-induced Bronchoconstriction Diagnostics: Impact of a Repeated Exercise Challenge Test

Completed
Conditions
Exercise Induced Bronchoconstriction
Registration Number
NCT01214551
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The purpose of this study is to increase the knowledge of the possible diagnostic effect of exercise induced bronchoconstriction performing a repeated exercise challenge test.

Detailed Description

Prior studies have shown that the intensity influences the sensitivity of exercise challenge tests (ECT) and that a heart rate-based protocol does not ensure sufficient exercise intensity to induce bronchoconstriction. It is not common clinical practice to perform a pre ECT to establish maximal heart rate or maximal oxygen uptake. The heart rate formula recommended by ATS (HRmax= 220-age) is usually applied to determine recommended intensity of the ECT. Conducting a second ECT, based on the knowledge of the first test, introduce the possibility to adjust the intensity on an individual basis. In addition, based on clinical experience, patients may seem reluctant to perform maximal the first time they undergo an ECT on a treadmill. The hypothesis is that patients are less reluctant to perform maximal the second time they undergo the test when they are more accustomed to the procedure and the treadmill by itself.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Referred to Klinikk for allergi og luftveissykdommer

  • Meet at least 3 out of 5 criteria (symptoms related to exercise):

    1. Cough during exercise or within 5 minutes after exercise
    2. Wheeze during exercise or within 5 minutes after exercise
    3. Heavy breathing, expiratory in particular, during exercise or within 5 minutes after exercise (duration 5 minutes or more)
    4. Improvement of physical fitness/breath is lacking despite of exercise intensification
    5. Chest tightness during or after exercise
  • Patients former diagnosed with-and treated for asthma who have symptoms of EIB are included in the study.

Exclusion Criteria
  • Ongoing respiratory infection or recent respiratory infection, judged by the responsible doctor to be of importance of the result
  • The inability to perform an Exercise challenge test with maximum effort

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Forced expiratory volume in one second (FEV1)up to 4 weeks
Secondary Outcome Measures
NameTimeMethod
Forced expiratory flow at 50 % FVC(FEF50%)up to 4 weeks
Fractional exhaled nitric oxide (FENO)up to 4 weeks
Total lung capacity (TLC)up to 4 weeks
Specific airway resistance (sRAW)up to 4 weeks
Specific airway conductance (sGAW)up to 4 weeks
Residual volume (RV)up to 4 weeks
Diffusing capacity (TLCO)up to 4 weeks
Maximum voluntary ventilation (MVV)up to 4 weeks
Breathing reserve (BR)up to 4 weeks
Respiratory exchange ration (RER)up to 4 weeks
Oxygen uptake peak (VO2 peak)up to 4 weeks
Heart rate peak (HR peak)up to 4 weeks
Ventilation peak (VE peak)up to 4 weeks
Forced vital capacity (FVC)up to 4 weeks

Trial Locations

Locations (1)

Klinikk for allergi og luftveissykdommer

🇳🇴

Oslo, Ullevål, Norway

© Copyright 2025. All Rights Reserved by MedPath